Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Capra Science Antibodies AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 477 Less Arrow 466 More Arrow 519
Financial expenses 4 Less Arrow 3 Less Arrow 1
Earnings before taxes 16 More Arrow 18 More Arrow 61
EBITDA 65 Less Arrow 52 More Arrow 86
Total assets 399 Less Arrow 351 More Arrow 428
Current assets 188 Less Arrow 175 More Arrow 248
Current liabilities 92 Less Arrow 88 More Arrow 167
Equity capital 234 Less Arrow 229 Less Arrow 214
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 3 Equal arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 58.6% More Arrow 65.2% Less Arrow 50.0%
Turnover per employee 159 Less Arrow 155 More Arrow 173
Profit as a percentage of turnover 3.4% More Arrow 3.9% More Arrow 11.8%
Return on assets (ROA) 5.0% More Arrow 6.0% More Arrow 14.5%
Current ratio 204.3% Less Arrow 198.9% Less Arrow 148.5%
Return on equity (ROE) 6.8% More Arrow 7.9% More Arrow 28.5%
Change turnover 27 Less Arrow -55 More Arrow 0
Change turnover % 6% Less Arrow -10% More Arrow 0%
Chg. No. of employees 0 Equal arrow 0 Less Arrow -1
Chg. No. of employees % 0% Equal arrow 0% Less Arrow -25%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.